Aushon Technology Chosen for Small Molecule Microarray Research

Aushon`s 2470 microarray printer provides customized solution for innovative
alternative to high-throughput screening at the Broad Institute
BILLERICA, Mass.--(Business Wire)--
Aushon BioSystems, Inc., a leading provider of advanced microarray
instrumentation and laboratory services for biomarker discovery, development and
analysis recently announced that the Eli and Edythe L. Broad Institute of MIT
and Harvard will utilize Aushon`s 2470 Arrayer technology for their small
molecule microarray research.

"The ability and willingness of Aushon to customize the capabilities of the 2470
Arrayer for our specific small molecule microarray application was critical,"
said Angela Koehler, Ph.D., Institute Fellow of Chemical Biology at the Broad
Institute. "Through our collaboration with Aushon, we were able to exploit the
advanced capabilities of the 2470 microarray printing platform while adapting it
to meet the stringent criteria of our own applications."

"Our partnership with the Broad Institute resulted in a solution that will
significantly impact the success of their innovative research efforts," said
Pete Honkanen, CEO of Aushon. "At the same time, it provided us with vital
insights into new applications for our printing platform, and enhanced the reach
and scope of our microarray technology."

The 2470 Arrayer has been installed in leading research institutions throughout
North America, Europe and Asia to provide rapid, accurate, high-density
microarray printing for both genomic and proteomic applications. It is able to
print virtually any sample - including cell lysates and blood - onto substrates
with unique shapes and chemistries, as well as the most delicate of substrates
such as nitrocellulose and silicon chips. Engineered with walk-away automation,
the unique solid pin architecture and proprietary pin design make the 2470 the
most flexible and reliable microarray printing platform available.

About the Broad Institute of MIT and Harvard

The Eli and Edythe L. Broad Institute of MIT and Harvard was founded in 2003 to
empower this generation of creative scientists to transform medicine with new
genome-based knowledge. The Broad Institute seeks to describe all the molecular
components of life and their connections; discover the molecular basis of major
human diseases; develop effective new approaches to diagnostics and
therapeutics; and disseminate discoveries, tools, methods and data openly to the
entire scientific community.

Founded by MIT, Harvard and its affiliated hospitals, and the visionary Los
Angeles philanthropists Eli and Edythe L. Broad, the Broad Institute includes
faculty, professional staff and students from throughout the MIT and Harvard
biomedical research communities and beyond, with collaborations spanning over a
hundred private and public institutions in more than 40 countries worldwide. For
further information about the Broad Institute, go to www.broad.mit.edu.

About Aushon BioSystems

Aushon BioSystems provides a comprehensive suite of microarray instruments,
consumables and services to leading pharmaceutical, biotechnology, academic and
diagnostic clients worldwide. Our unique combination of advanced microarray
printing technology, robust biomarker content and innovative multiplex
immunoassay development and detection systems delivers exceptional performance,
quality and reliability that accelerates pre-clinical and clinical biomarker
research. Our customers trust us to provide the most reliable protein biomarker
data available, which lowers costs and improves research productivity. For more
information, please visit www.aushon.com.

Aushon BioSystems
Alan Poon, 978-436-6428
Director of Marketing
alan.poon@aushon.com

Copyright Business Wire 2009